Back to today’s briefing

Story perspectives

Kenvue Urges FDA to Reject Autism Warning for Tylenol

10/21/2025

22 4

Summary

Story summary

Kenvue asks U.S. regulators to reject a petition seeking an autism warning label on Tylenol during pregnancy.
The petition links acetaminophen to autism, but Kenvue says the evidence does not support that claim.
The U.S. Food and Drug Administration (FDA) notes studies show an association but has not established a causal relationship.
Acetaminophen remains the only pain reliever considered safe for use in pregnancy.

1 of 1

Story summary

Kenvue asks U.S. regulators to reject a petition seeking an autism warning label on Tylenol during pregnancy.
The petition links acetaminophen to autism, but Kenvue says the evidence does not support that claim.
The U.S. Food and Drug Administration (FDA) notes studies show an association but has not established a causal relationship.
Acetaminophen remains the only pain reliever considered safe for use in pregnancy.